Literature DB >> 6379179

Preparation and antibacterial activities of new 1,2,3-diazaborine derivatives and analogues.

M A Grassberger, F Turnowsky, J Hildebrandt.   

Abstract

1,2-Dihydro-1-hydroxy-2-(organosulfonyl)areno[d] [1,2,3]diazaborines 2 (arene = benzene, naphthalene, thiophene, furan, pyrrole) were synthesized by reaction of (organosulfonyl)hydrazones of arene aldehydes or ketones with tribromoborane in the presence of ferric chloride. The activities of 2 against bacteria in vitro and in vivo (Escherichia coli) were determined and structure-activity relationships are discussed. Included in this study are 2,3-dihydro-1-hydroxy-2-(p-tolylsulfonyl)-1H-2,1-benzazaborole+ ++ (3) and 1-hydroxy-1,2,3,4-tetrahydro-2-(p-tolylsulfonyl)-2,1-benzazabor ine (4) as well as the carbacyclic benzodiazaborine analogue 4-hydroxy-3-(p-tolylsulfonyl)isoquinoline (7). The nature of the active species is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379179     DOI: 10.1021/jm00374a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.

Authors:  Shahila Mehboob; Kirk E Hevener; Kent Truong; Teuta Boci; Bernard D Santarsiero; Michael E Johnson
Journal:  J Med Chem       Date:  2012-06-08       Impact factor: 7.446

2.  Molecular basis for triclosan activity involves a flipping loop in the active site.

Authors:  X Qiu; C A Janson; R I Court; M G Smyth; D J Payne; S S Abdel-Meguid
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 3.  Targeting InhA, the FASII enoyl-ACP reductase: SAR studies on novel inhibitor scaffolds.

Authors:  Pan Pan; Peter J Tonge
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

4.  In vivo evidence that S-adenosylmethionine and fatty acid synthesis intermediates are the substrates for the LuxI family of autoinducer synthases.

Authors:  D L Val; J E Cronan
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

5.  Accessing Elaborated 2,1-Borazaronaphthalene Cores Using Photoredox/Nickel Dual-Catalytic Functionalization.

Authors:  Matthieu Jouffroy; Geraint H M Davies; Gary A Molander
Journal:  Org Lett       Date:  2016-03-17       Impact factor: 6.005

6.  Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.

Authors:  Cheryl A Jordan; Braddock A Sandoval; Mkrtich V Serobyan; Damian H Gilling; Michael P Groziak; H Howard Xu; Jessica L Vey
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-11-27       Impact factor: 1.056

7.  Identification of cellular targets of a series of boron heterocycles using TIPA II-A sensitive target identification platform.

Authors:  Matthew S Ward; Isba Silva; Walfre Martinez; Jameka Jefferson; Shakila Rahman; Jeanie M Garcia; Divya Kanichar; Lance Roppiyakuda; Ewa Kosmowska; Michelle A Faust; Kim P Tran; Felicia Chow; Elena Buglo; Feimeng Zhou; Michael P Groziak; H Howard Xu
Journal:  Bioorg Med Chem       Date:  2016-06-04       Impact factor: 3.641

8.  A convergent, modular approach to functionalized 2,1-borazaronaphthalenes from 2-aminostyrenes and potassium organotrifluoroborates.

Authors:  Steven R Wisniewski; Courtney L Guenther; O Andreea Argintaru; Gary A Molander
Journal:  J Org Chem       Date:  2013-12-11       Impact factor: 4.354

9.  Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.

Authors:  Gang Cheng; Stephen P Muench; Ying Zhou; Gustavo A Afanador; Ernest J Mui; Alina Fomovska; Bo Shiun Lai; Sean T Prigge; Stuart Woods; Craig W Roberts; Mark R Hickman; Patty J Lee; Susan E Leed; Jennifer M Auschwitz; David W Rice; Rima McLeod
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

10.  Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.

Authors:  Gustavo A Afanador; Stephen P Muench; Martin McPhillie; Alina Fomovska; Arne Schön; Ying Zhou; Gang Cheng; Jozef Stec; Joel S Freundlich; Hong-Ming Shieh; John W Anderson; David P Jacobus; David A Fidock; Alan P Kozikowski; Colin W Fishwick; David W Rice; Ernesto Freire; Rima McLeod; Sean T Prigge
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.